UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| 1 |
Vanguard Mid-Cap ETF
VO
|
$547M |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
$421M |
| 3 |
Vanguard Short-Term Treasury ETF
VGSH
|
$353M |
| 4 |
SPDR Gold Trust
GLD
|
$295M |
| 5 |
Alibaba
BABA
|
$258M |
Top Sells
| 1 |
AGN
Allergan plc
AGN
|
$1.21B |
| 2 |
Microsoft
MSFT
|
$1.21B |
| 3 |
iShares US Treasury Bond ETF
GOVT
|
$1.14B |
| 4 |
SPDR S&P 500 ETF Trust
SPY
|
$832M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
$421M |
Sector Composition
| 1 | Technology | 13.83% |
| 2 | Healthcare | 8.03% |
| 3 | Consumer Discretionary | 8.01% |
| 4 | Financials | 7.69% |
| 5 | Communication Services | 5.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
326
Southern Company
SO
$101B
| $85.8M | 0.04% |
1,654,618
-104,573
| -6% | -$5.42M |
|
327
First Trust Cloud Computing ETF
SKYY
$3.03B
| $85.7M | 0.04% |
1,149,665
+252,922
| +28% | +$18.8M |
|
328
Progressive
PGR
$145B
| $85.5M | 0.04% |
1,067,513
+297,691
| +39% | +$23.8M |
|
329
Conagra Brands
CAG
$9.19B
| $84.7M | 0.04% |
2,407,802
-238,047
| -9% | -$8.37M |
|
330
Biogen
BIIB
$20.8B
| $84.5M | 0.04% |
315,940
+52,443
| +20% | +$14M |
|
331
Materials Select Sector SPDR Fund
XLB
$5.46B
| $84M | 0.04% |
1,491,192
-134,837
| -8% | -$7.6M |
|
332
Lam Research
LRCX
$124B
| $83.9M | 0.04% |
259,255
-117,893
| -31% | -$38.1M |
|
333
Applied Materials
AMAT
$124B
| $83.7M | 0.04% |
1,385,382
-240,194
| -15% | -$14.5M |
|
334
iShares S&P Small-Cap 600 Growth ETF
IJT
$6.21B
| $83.4M | 0.04% |
491,295
-14,895
| -3% | -$2.53M |
|
335
Vanguard Extended Market ETF
VXF
$23.7B
| $83.2M | 0.04% |
703,395
-144,708
| -17% | -$17.1M |
|
336
Eaton
ETN
$134B
| $82.5M | 0.03% |
943,108
-549,047
| -37% | -$48M |
|
|
SAFE
337
Safehold
SAFE
$1.16B
| $81.2M | 0.03% |
6,586,870
-128,939
| -2% | -$1.59M |
|
338
Deere & Co
DE
$127B
| $80M | 0.03% |
508,827
+5,485
| +1% | +$862K |
|
339
Vanguard Total International Bond ETF
BNDX
$68B
| $79.3M | 0.03% |
1,372,972
-378,495
| -22% | -$21.9M |
|
340
First Trust NYSE Arca Biotechnology Index Fund
FBT
$1.07B
| $79.2M | 0.03% |
472,275
+85,471
| +22% | +$14.3M |
|
341
Regeneron Pharmaceuticals
REGN
$59.8B
| $79.1M | 0.03% |
126,884
+30,814
| +32% | +$19.2M |
|
342
Schwab US Mid-Cap ETF
SCHM
$12B
| $78.9M | 0.03% |
1,499,628
+146,176
| +11% | +$7.69M |
|
343
iShares MSCI India ETF
INDA
$9.29B
| $78.6M | 0.03% |
2,707,640
+2,197,541
| +431% | +$63.8M |
|
344
Vanguard Intermediate-Term Bond ETF
BIV
$24B
| $78.1M | 0.03% |
838,362
+125,547
| +18% | +$11.7M |
|
345
iShares Russell 2000 Value ETF
IWN
$11.7B
| $77.7M | 0.03% |
797,733
+12,869
| +2% | +$1.25M |
|
346
Vertex Pharmaceuticals
VRTX
$102B
| $77.5M | 0.03% |
266,788
-102,485
| -28% | -$29.8M |
|
347
MetLife
MET
$53.6B
| $76.6M | 0.03% |
2,096,369
-1,412,771
| -40% | -$51.6M |
|
348
iShares ESG Aware MSCI EAFE ETF
ESGD
$9.81B
| $76M | 0.03% |
1,254,550
+194,846
| +18% | +$11.8M |
|
349
SPDR Portfolio S&P 400 Mid Cap ETF
SPMD
$14.1B
| $75.1M | 0.03% |
2,403,207
+2,250,883
| +1,478% | +$70.3M |
|
350
Deutsche Bank
DB
$67B
| $74.9M | 0.03% |
7,865,635
+2,698,731
| +52% | +$25.7M |
|